ProSolv CardioVascular

ProSolv CardioVascular (Booth 443), a Fujifilm company, is introducing its ProSolv CardioVascular 4.0, a new software application.

The web-based application for full viewing and reporting capabilities using web communication protocols, secured via SSL, in addition to a web URL single-click application download and installation. Other enhancements include new clinical tools to further aid the diagnostic process, and the full integration to Fujifilm Medical Systems’ Synapse PACS.  

For pediatric echo, reporting and a Z-score module have been added so users can report more than 40 pediatric measurements and calculations against the normal ranges and Z-scores. For nuclear cardiology, Invia 4DM-SPECT version 5.2 is now supported, offering features like saved state. Other new features and enhancements introduced in ProSolv CardioVascular 4.0 include a new default echo measurement analysis package, improvements to ProSolv CardioVascular’s coronary tree functionality, and resting ECG management, including Holter Monitoring support delivered by ProSolv CardioVascular’s OpenECG Module, powered by Epiphany.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.